Showing results (1361-1370 of 1,994) with videos related to

Sort By:
Pageof 200
British Journal of Cancer|September 10, 2009
Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survivalJ A M Belien, T E Buffart, A J Gill, et al.
The American Journal of Surgical Pathology|November 20, 2019
Assessment of Tumor-infiltrating Lymphocytes Using International TILs Working Group (ITWG) System Is a Strong Predictor of Overall Survival in Colorectal Carcinoma: A Study of 1034 PatientsTalia L Fuchs, Loretta Sioson, Amy Sheen, et al.
AIDS (London, England)|September 1, 1989
Nature, time course and dose dependence of zidovudine-related side effects: results from the Multicenter Canadian Azidothymidine TrialK Gelmon, J S Montaner, M Fanning, et al.
Pathology|April 27, 2016
Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasmsJuliana Andrici, Mahtab Farzin, Adele Clarkson, et al.
Brain and Behavior|May 14, 2026
The Effect of Ocrelizumab on Anti-JC Virus Antibody IndexAkash Virupakshaiah, Alexander J Gill, Vinicius A Schoeps, et al.
Tissue Engineering. Part A|March 23, 2012
Properties of cartilage engineered from elderly human chondrocytes for articular surface repairXing Zhao, David A Bichara, Frederick P Ballyns, et al.
Tissue Engineering. Part A|June 22, 2016
Hyaline Articular Matrix Formed by Dynamic Self-Regenerating Cartilage and HydrogelsAmanda M Meppelink, Xing Zhao, Darvin J Griffin, et al.
Endocrine Pathology|February 16, 2019
MiRNA-3653 Is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine TumoursPreetjote Gill, Edward Kim, Terence C Chua, et al.
ANZ Journal of Surgery|March 21, 2017
Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: analysis of early outcome dataPhil Townend, Phil R de Reuver, Terence C Chua, et al.
European Journal of Clinical Investigation|April 8, 2025
Total lesion glycolysis is a promising predictor of chemo-response in pancreatic cancer patients treated with neoadjuvant chemotherapy prior to surgerySooin Byeon, Bridget Abbott, Paul Roach, et al.
Pageof 200